<DOC>
	<DOC>NCT01055964</DOC>
	<brief_summary>The aim of this study is to identify the pharmacokinetic differences between two oral forms of Tacrolimus and consequent nephrotoxicity.</brief_summary>
	<brief_title>a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>ABOcompatible renal transplant recipients multiorgan transplant HIV(+) donor or recipients history of malignancy other than skin cancer (except completely cured basal cell ca or squamous cell ca) more than threefold increase in AST or ALT level for 28 days pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>